Skip to main content
Skip to main content
Go to homepage

Somapacitan with Daily Norditropin® for Small Stature

Somapacitan Once a Week with Daily Norditropin® in Children Who Need Help to Grow

Description:

For complete details, please view the study on Clinicaltrials.gov

Who May Qualify?:

For complete details, please view the study on Clinicaltrials.gov

Who Does Not Qualify:

For complete details, please view the study on Clinicaltrials.gov

Interested in participating?
We are currently recruiting
Study Sponsor:

NovoNordisk A/S

Full IRB Study Title:
A study comparing the effect and safety of once weekly dosing of somapacitan with daily Norditropin® as well as evaluating long-term safety of somapacitan in a basket study design in children with short stature either born small for gestational age or with Turner syndrome, Noonan syndrome, or idiopathic short stature
IRB Study ID:
2023-055
If you are interested in this study or have questions about your child's eligibility, please contact:

JoAnn Katz, BSN, RN, CCRC

(330)543-0690

Lead Investigator
Naveen Uli, MD

Medical Director, Center for Diabetes and Endocrinology; Pediatric Endocrinologist

By using this site, you consent to our use of cookies. To learn more, read our privacy policy.